Treatment of Lower Extremity Spider Veins With Excel V

Inclusion Criteria: * Fitzpatrick Skin Type I - III * Having at least 2 separate areas measuring 5cm x 5cm of lower extremity spider veins * Having lower extremity spider veins less than 2.0mm in diameter, linear or branching, and red, pink, blue and/or purple in color, as assessed by the Investigator * Having lower extremity spider veins appropriate for laser treatment, as assessed by the Investigator * Subject must be able to read, understand and sign the Informed Consent Form * Subject must be willing and able to adhere to the treatment and follow-up schedule and post-treatment care instructions * Wiling to have limited sun exposure for the duration of the study, including the follow-up period * Willingness to have digital photographs taken of lower extremity spider veins * Agree not to undergo any other procedure for the treatment of lower extremity spider veins during the study * Willing to not take any 'prn' medications for aches and pains (such as Tylenol® or Advil®) on the days of the laser treatments * For female candidates - post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study Exclusion Criteria: * Having received any prior laser treatment for lower extremity spider veins * Fitzpatrick Skin Type IV - VI * Pregnant * Having an infection, dermatitis or a rash in the treatment area * Having significant varicosities or perforator veins * History of keloid scarring, hypertrophic scarring or of abnormal wound healing * History of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications * History of connective tissue disease, such as systemic lupus erythematosus or scleroderma * History of pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation * Having a known anticoagulative condition or taking anticoagulation medications * History of thromboembolic disease, such as deep vein thrombosis (DVT) * History of seizure disorders due to light * Having a history of diseases stimulated by heat, such as recurrent herpes simplex in the treatment area, unless treatment is conducted following a prophylactic regimen * Having undergone any surgery in the treatment area within 6 months of treatment (or more if skin has not healed completely) * Suffering from significant concurrent illness, such as insulin-dependent diabetes (type I or II), peripheral vascular disease or peripheral neuropathy * Undergoing systemic chemotherapy for the treatment of cancer * Systemic use of isotretinoin (Accutane®) within 6 months of study participation * Any use of gold therapy for disorders such as rheumatologic disease or lupus * Excessively tanned in areas to be treated or unable/unlikely to refrain from tanning during the study * Participation in a study of another device or drug within three months prior to enrollment or during the study * As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study